Found: 1
Select item for more details and to access through your institution.
Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild to moderate Alzheimer’s disease: A phase ii multicenter randomized controlled trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P902, doi. 10.1016/j.jalz.2015.08.138
- By:
- Publication type:
- Article